Concepedia

Eva Liliemark

EL

Statistics

Publications

15

Citations

360

H-Index

12

Active since

1993

Affiliations

Karolinska University Hospital(Current)

Karolinska Institutet

Sophiahemmet Hospital

Swedish University of Agricultural Sciences

Eva Liliemark is an author at Karolinska University Hospital specializing in medicine, hematology, and biochemistry.

Top concepts

Publications per year

1993–2002

15

Publications

15

P-Glycoprotein Inhibitor Valspodar (PSC 833) Increases the Intracellular Concentrations of Daunorubicin In Vivo in Patients With P-Glycoprotein–Positive Acute Myeloid Leukemia

Ulf Tidefelt, Jan Liliemark, Astrid Gruber et al. · Journal of Clinical Oncology · 2000 · 98 citations

High-performance liquid chromatography with fluorometric detection for monitoring of etoposide and its cis-isomer in plasma and leukaemic cells

Eva Liliemark, Birgitta Pettersson, Curt Peterson et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1995 · 33 citations

, , +12

Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide

Kourosh Lotfi, Emma Månsson, Joya Chandra et al. · British Journal of Haematology · 2001 · 32 citations

DNA damage induced by etoposide; a comparison of two different methods for determination of strand breaks in DNA

Solveig Walles, Rong Zhou, Eva Liliemark · Cancer Letters · 1996 · 31 citations

, , +11

In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells

Yuying Wang, Staffan Eksborg, Rolf Lewensohn et al. · Anti-Cancer Drugs · 1999 · 27 citations

1–5 of 15